# Ardent Health (ARDT) — Analyst Forecast

ARDT · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/ardt/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 5 | 1 | 13 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $11.00 | $13.00 | $14.00 | 5 |

Last price $12.20 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 23, 2026 | BMO Capital | Initiated Coverage | Market Perform | $11.00 |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | $14.00 |
| Aug 10, 2026 | RBC Capital | Maintained | Outperform | $13.00 |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | $14.00 |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | $13.00 |
| Jul 14, 2026 | Truist Securities | Maintained | Buy | $12.00 |
| Jul 9, 2026 | RBC Capital | Maintained | Outperform | $12.00 |
| May 7, 2026 | UBS | Maintained | Buy | $13.50 |
| Mar 10, 2026 | RBC Capital | Maintained | Outperform | $13.00 |
| Mar 6, 2026 | Leerink Partners | Maintained | Outperform | $15.00 |
| Jan 20, 2026 | JP Morgan | Maintained | Neutral | $11.00 |
| Dec 18, 2025 | Mizuho | Maintained | Outperform | $12.00 |
| Dec 18, 2025 | UBS | Maintained | Buy | $14.00 |
| Nov 24, 2025 | JP Morgan | Maintained | Neutral | $12.00 |
| Nov 18, 2025 | Guggenheim | Maintained | Buy | $15.00 |
| Nov 18, 2025 | Mizuho | Maintained | Outperform | $13.00 |
| Nov 17, 2025 | Keybanc | Downgraded | Overweight → Sector Weight | — |
| Nov 14, 2025 | Morgan Stanley | Downgraded | Overweight → Equal-Weight | $12.00 |
| Nov 14, 2025 | Stephens & Co. | Maintained | Overweight | $17.00 |
| Nov 14, 2025 | Truist Securities | Maintained | Buy | $13.00 |

## Frequently Asked Questions

### What is the price target for ARDT stock?

The average 12-month analyst price target for Ardent Health (ARDT) is $13.00, with a high estimate of $14.00 and a low of $11.00, across 5 analysts.

### Is ARDT a buy, sell, or hold?

Analysts covering Ardent Health currently average a Buy rating: 7 buy, 5 hold and 1 sell, from 13 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ARDT?

The average price target of $13.00 implies 6.56% upside from the last price of $12.20.

### What is the latest analyst rating on ARDT?

On Sep 23, 2026, BMO Capital initiated coverage of Ardent Health at Market Perform with a price target of $11.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).